Cognitive deficits in schizophrenia: Early course and treatment

Clinical Neuroscience Research

Volumn 3, Issue 1-2, 2003, Pages 17-22

  Harvey, Philip D ^a   Bowie, Christopher R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive deficits; Cognitive enhancement; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ALERTNESS; ATTENTION; AWARENESS; CLINICAL STUDY; COGNITION; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; LEARNING; MEDICAL LITERATURE; MEMORY; MOTOR PERFORMANCE; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOM; TASK PERFORMANCE; THINKING; TREATMENT OUTCOME; VERBAL BEHAVIOR; WORKING MEMORY;

EID: 0041529518     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(03)00015-X     Document Type: Review

References (52)

1. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 1996 321-330
2. Gold J.M. Harvey P.D. Cognitive deficits in schizophrenia Psychiatric Clin N Am 16 1993 295-312
3. Harvey P.D. Keefe R.S.E. Cognitive impairment in schizophrenia and the implications of atypical neuroleptic treatment CNS Spectrums 2 1997 41-55
4. Harvey P.D. Docherty N. Serper M.R. Rasmussen M. Cognitive deficits and thought disorder: II. An eight-month followup study Schizophr Bull 16 1990 147-156
5. Chen W.J. Liu S.K. Chang C.J. et al. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients Am J Psychiatry 155 1998 1214-1220
6. Cornblatt B.A. Erlenmeyer-Kimling L. Global attentional deviance as a marker of risk for schizophrenia: Specificity and predictive validity J Abnorm Psychol 94 1985 470-486
7. Keefe R.S.E. Silverman J.M. Lees Roitman S.E. et al. Performance of nonpsychotic first degree relatives of schizophrenic patients on cognitive tests Psychiatry Res 53 1994 1-12
8. Cornblatt B. Obuchowski M. Roberts S. et al. Cognitive and behavioral precursors of schizophrenia Dev Psychopathol 11 1999 487-508
9. David A.S. Malmberg A. Brandt L. et al. IQ and risk for schizophrenia: a population-based cohort study Psychol Med 27 1997 1311-1323
10. Davidson M. Reichenberg A. Rabinowitz J. et al. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents Am J Psychiatry 156 1999 1328-1335
11. Crow T.J. Done D.J. Sacker A. Childhood precursors of psychosis as clues to its evolutionary origins Eur Arch Psychiatry Clin Neurosci 245 1995 61-69
12. Jones P. Rodgers B. Murray R. et al. Child development risk factors for adult schizophrenia in the British 1946 birth cohort Lancet 344 1994 1398-1402
13. Reichenberg A. Rabinowitz J. Weiser M. et al. Premorbid functioning in a national population of male twins discordant for psychoses Am J Psychiatry 157 2000 1514-1516
14. Davidson M. Harvey P.D. Welsh K.A. et al. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease Am J Psychiatry 153 1996 1274-1279
15. Heaton R. Paulsen J.S. McAdams L.A. et al. Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia Arch Gen Psychiatry 51 1994 469-476
16. Russell A.J. Munro J.C. Jones P.B. et al. Schizophrenia and the myth of intellectual decline Am J Psychiatry 154 1997 635-639
17. Gilvarry C. Takei N. Russell A. Premorbid I.Q. et al. in patients with functional psychosis and their first-degree relatives Schizophr Res 41 2000 417-429
18. Rabinowitz J. Reichenberg A. Weiser M. et al. Cognitive and behavioral functioning in schizophrenia before the first hospitalization and shortly after: a cross-sectional analysis of registry data Br J Psychiatry 177 2000 26-32
19. Weickert T.W. Goldberg T.E. Gold J.M. et al. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect Arch Gen Psychiatry 57 2000 907-913
20. Saykin A.J. Shtasel D.L. Gur R.E. et al. Neuropsychological deficits in neuroleptic naive patients with first- episode schizophrenia Arch Gen Psychiatry 51 1994 124-131
21. Mohamed S. Paulsen J.S. O'Leary D. et al. Generalized cognitive deficits in schizophrenia: a study of first- episode patients Arch Gen Psychiatry 56 1999 749-754
22. Bilder R.M. Goldman R.S. Robinson D. et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates Am J Psychiatry 157 2000 549-559
23. Mojtabai R. Bromet E. Harvey P.D. et al. Are there neuropsychological differences between first episode patients with schizophrenia and affective disorder? Am J Psychiatry 157 2000 1453-1460
24. Gold S. Arndt S. Nopoulos P. et al. Longitudinal study of cognitive functioning in first episode and recent onset schizophrenia Am J Psychiatry 156 1999 1342-1348
25. Hoff A.L. Sakuma M. Wieneke M. et al. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia Am J Psychiatry 156 1999 1336-1341
26. Sweeney J.A. Haas G.L. Keilp J.G. et al. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year follow up study Psychiatry Res 38 1991 63-76
27. Wyatt R.J. Neuroleptics and the natural course of schizophrenia Schizophr Bull 17 1991 325-351
28. Loebel A.D. Lieberman J.A. Alvir J.M. et al. Duration of psychosis and outcome in first-episode schizophrenia Am J Psychiatry 149 1992 1183-1188
29. Robinson D.G. Werner M.G. Alvir J.M. et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder Am J Psychiatry 156 1999 544-549
30. Craig T.J. Bromet E.J. Fennig S. et al. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 157 2000 60-66
31. Ho B.-C. Andreasen N.C. Flaum M. et al. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia Am J Psychiatry 157 2000 808-815
32. Tsuang M.T. Stone W.S. Seidman L.J. et al. Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies Biol Psychiatry 45 1999 1412-1418
33. Hegarty J.D. Baldessarini R.J. Tohen M. One hundred years of schizophrenia: A meta-analysis of the outcome literature Am J Psychiatry 151 1994 1409-1416
34. Medalia A. Gold J. Merriam A. The effects of antipsychotics on neuropsychological test results of schizophrenics Arch Clin Neuropsychol 3 1988 249-271
35. Blyler C.R. Gold J.M. Cognitive effects of typical antipsychotic medication treatment: another look in: Sharma T. Harvey P.D. (Eds.), Cognition in schizophrenia 2000 241-265 Oxford University Press Oxford
36. Spohn H.E. Strauss M.E. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia J Abnorm Psychol 98 1989 478-486
37. Strauss M.E. Reynolds K.S. Jayaram G. Tune L.E. Effects of anticholinergic medication on memory in schizophrenia Schizophr Res 3 1990 127-129
38. Serper M.R. Davidson M. Harvey P.D. Attentional predictors of clinical change during neuroleptic treatment Schizophr Res 13 1994 65-71
39. Buchanan R.W. Holstein C. Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance Biol Psychiatry 36 1994 717-725
40. Hagger C. Buckley P. Kenny J.T. Friedman L. Ubogy D. Meltzer H.Y. Improvement in cognitive function and psychotic symptoms in treatment-refractory schizophrenic patients Biol Psychiatry 34 1993 702-712
41. Keefe R.S.E. Perkins S. Silva S.M. Lieberman J.A. The effect of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis Schizophr Bull 25 1999 201-222
42. Harvey P.D. Keefe R.S.E. Interpreting studies of cognitive change in schizophrenia with novel antipsychotic treatment Am J Psychiatry 158 2001 176-184
43. Purdon S.E. Jones B.D. Stip E. et al.. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia Arch Gen Psychiatry 57 2000 249-258
44. Bilder R.M. Goldman R.S. Volavka J. et al.. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder Am J Psychiatry 1259 2002 1018-1028
45. Harvey PD, Green MF, Meltzer HY. The cognitive effects of risperidone and olanzapine in patients with schizoaffective disorder or schizophrenia. Psychopharmacology (in press).
46. Seidman L.J. Pepple J.R. Faraone S.V. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction Biol Psychiatry 33 1993 575-584
47. Green M.F. Marder S.R. Glynn S.M. et al. The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone Biol Psychiatry 2002 972-978
48. Carpenter W.T. Jr Gold J.M. Another view of therapy for cognition in schizophrenia Biol Psychiatry 51 2002 969-971
49. Keefe RSE. Treatment of cognitive deficits with olanzapine or low-dose haloperidol in first episode psychosis. Presented at the second meeting of the International Early Psychosis Association: New York, 2000.
50. Delis D.C. Kramer J.H. Kaplan E. et al. California Verbal Learning Test-Research Edition, Manual 1987 The Psychological Corporation New York
51. Friedman J.I. Adler D.N. Temporini H.D. et al. Guanfacine treatment of cognitive impairment in schizophrenia: A pilot study Neuropsychopharmacology 25 2001 402-409
52. Friedman J.I. Adler D.N. Howanitz E. et al.. A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia Biol Psychiatry 51 2002 349-357